S. 2008

119 S2008 IS: Stop Funding Genital Mutilation Act
 U.S. Senate
 2025-06-10
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  II
  119th CONGRESS
  1st Session
  S. 2008
  IN THE SENATE OF THE UNITED STATES
  June 10, 2025
  Mr. Cornyn  (for himself and  Mr. Lankford ) introduced the following bill; which
  was read twice and referred to the  Committee
  on Finance
  A BILL
To amend title XIX of the Social Security Act to prohibit Medicaid and CHIP
  funding for gender transition procedures.
1.
Short title
This Act may be cited as the   Stop Funding Genital Mutilation Act  .
2.
Prohibiting Federal Medicaid and CHIP
  funding for gender transition procedures
(a)
Medicaid
Section 1903(i) of the  Social Security Act  ( 42 U.S.C. 1396b(i) ) is amended—
(1)
in paragraph (26), by striking  ; or  and inserting a semicolon;
(2)
in paragraph (27), by striking the period at the end and inserting  ; or ;
(3)
by inserting after paragraph (27) the following new paragraph:
(28)
with respect to any amount expended for specified gender transition procedures (as defined in section 1905(kk)) furnished to an individual enrolled in a State plan (or waiver of such plan).
  ; and
(4)
in the flush left matter at the end, by striking  and (18),  and inserting  (18), and (28) .
(b)
CHIP
Section 2107(e)(1)(N) of the  Social Security Act  ( 42 U.S.C. 1397gg(e)(1)(N) ) is amended by striking  and (17)  and inserting  (17), and (28) .
(c)
Specified gender transition procedures defined
Section 1905 of the  Social Security Act  ( 42 U.S.C. 1396d ) is amended by adding at the end the following new subsection:
(kk)
Specified gender transition procedures
(1)
In general
For purposes of section 1903(i)(28), except as provided in paragraph (2), the term  specified gender transition procedure  means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual (including by disrupting the body's development, inhibiting its natural functions, or modifying its appearance) to no longer correspond to the individual's sex:
(A)
Performing any surgery, including—
(i)
castration;
(ii)
sterilization;
(iii)
orchiectomy;
(iv)
scrotoplasty;
(v)
vasectomy;
(vi)
tubal ligation;
(vii)
hysterectomy;
(viii)
oophorectomy;
(ix)
ovariectomy;
(x)
metoidioplasty;
(xi)
clitoroplasty;
(xii)
reconstruction of the fixed part of the urethra with or without a metoidioplasty or a phalloplasty;
(xiii)
penectomy;
(xiv)
phalloplasty;
(xv)
vaginoplasty;
(xvi)
vaginectomy;
(xvii)
vulvoplasty;
(xviii)
reduction thyrochondroplasty;
(xix)
chondrolaryngoplasty;
(xx)
mastectomy; and
(xxi)
any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other body features of an individual.
(B)
Any placement of chest implants to create feminine breasts or any placement of erection or testicular prostheses.
(C)
Any placement of fat or artificial implants in the gluteal region.
(D)
Administering, prescribing, or dispensing to an individual medications, including—
(i)
gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and
(ii)
testosterone, estrogen, or other androgens to an individual at doses that are supraphysiologic than would normally be produced endogenously in a healthy individual of the same age and sex.
(2)
Exception
Paragraph (1) shall not apply to the following when furnished to an individual by a health care provider with the consent of such individual's parent or legal guardian:
(A)
Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for an individual experiencing precocious puberty.
(B)
Medically necessary procedures or treatments to correct for—
(i)
a medically verifiable disorder of sex development, including—
(I)
46,XX chromosomes with virilization;
(II)
46,XY chromosomes with undervirilization; and
(III)
both ovarian and testicular tissue;
(ii)
sex chromosome structure, sex steroid hormone production, or sex hormone action, if determined to be abnormal by a physician through genetic or biochemical testing;
(iii)
infection, disease, injury, or disorder caused or exacerbated by a previous procedure described in paragraph (1), or a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including procedures performed for the alleviation of mental distress; or
(iv)
procedures to restore or reconstruct the body of the individual in order to correspond to the individual's sex after one or more previous procedures described in paragraph (1), which may include the removal of a pseudo phallus or breast augmentation.
(3)
Sex
For purposes of paragraph (1), the term  sex  means either male or female, as biologically determined and defined in paragraphs (4) and (5), respectively.
(4)
Female
For purposes of paragraph (3), the term  female  means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization.
(5)
Male
For purposes of paragraph (3), the term  male  means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization.
  .